Back
Aspen Aerogels 10K Form
Sell
22
ASPN
Aspen Aerogels
Last Price:
13.99
Seasonality Move:
7.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-02 | 10Q | ASPN/Aspen Aerogels Quarterly |
2023-08-03 | 10Q | ASPN/Aspen Aerogels Quarterly |
2023-05-04 | 10Q | ASPN/Aspen Aerogels Quarterly |
2022-11-07 | 10Q | ASPN/Aspen Aerogels Quarterly |
2022-08-04 | 10Q | ASPN/Aspen Aerogels Quarterly |
2022-05-10 | 10Q | ASPN/Aspen Aerogels Quarterly |
Receive ASPN News And Ratings
See the #1 stock for the next 7 days that we like better than ASPN
ASPN Financial Statistics
Sales & Book Value
Annual Sales: | $238.72M |
---|---|
Cash Flow: | $-50K |
Price / Cash Flow: | 0 |
Annual Sales: | $6.58 |
Price / Book: | 2.34 |
Profitability
EPS (TTM): | 0.01000 |
---|---|
Net Income (TTM): | $1.49M |
Gross Margin: | $56.92M |
Return on Equity: | 0.31% |
Return on Assets: | 0.21% |
Aspen Aerogels Earnings Forecast
Key Aspen Aerogels Financial Ratios
- The Gross Profit Margin over the past 15 years for ASPN is 23.84%.
- The Selling, General & Administrative Expenses for ASPN have been equal to 37.60% of Gross Profit Margin.
- The Research & Development expenses have been 6.85% of Revenue.
- The Interest Expense is -11.63% of Operating Income.
- The Net Earning history of ASPN is -19.19% of Total Revenues.
- Per Share Earnings over the last 15 years have been positive in 6 years.
Aspen Aerogels Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Chemicals |
Sector: | Materials |
Current Symbol: | ASPN |
CUSIP: | 04523Y |
Website: | aerogel.com |
Debt
Debt-to-Equity Ratio: | 0.32 |
---|---|
Current Ratio: | 2.93 |
Quick Ratio: | 2.19 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 28.12 |
ASPN Technical Analysis vs Fundamental Analysis
Sell
22
Aspen Aerogels (ASPN)
is a Sell
Is Aspen Aerogels a Buy or a Sell?
-
Aspen Aerogels stock is rated a Sell
The current Aspen Aerogels [ASPN] share price is $13.98. The Score for ASPN is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.